Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2020-03Submitted date
2019-07-10
Metadata
Show full item recordJournal
Journal of hepatologyPubMed ID
31730789Type
ArticleOther
Language
enEISSN
1600-0641ae974a485f413a2113503eed53cd6c53
10.1016/j.jhep.2019.11.003
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons